益盛药业(002566.SZ)发布前三季度业绩，归母净利润2413万元，同比下降32.72%

Core Insights - Yisheng Pharmaceutical (002566.SZ) reported a revenue of 476 million yuan for the first three quarters of 2025, representing a year-on-year decline of 5.81% [1] - The company's net profit attributable to shareholders was 24.13 million yuan, down 32.72% year-on-year [1] - The non-recurring net profit was 12.56 million yuan, reflecting a year-on-year decrease of 37.81% [1] - Basic earnings per share stood at 0.0729 yuan [1]